170 related articles for article (PubMed ID: 2909204)
1. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial.
Davidson CJ; Hlatky M; Morris KG; Pieper K; Skelton TN; Schwab SJ; Bashore TM
Ann Intern Med; 1989 Jan; 110(2):119-24. PubMed ID: 2909204
[TBL] [Abstract][Full Text] [Related]
2. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent.
Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM
N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
4. Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography.
Madsen TE; Pearson RR; Muhlestein JB; Lappé DL; Bair TL; Horne BD; Anderson JL;
Crit Pathw Cardiol; 2009 Dec; 8(4):167-71. PubMed ID: 19952552
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography.
Campbell DR; Flemming BK; Mason WF; Jackson SA; Hirsch DJ; MacDonald KJ
Can Assoc Radiol J; 1990 Jun; 41(3):133-7. PubMed ID: 2354386
[TBL] [Abstract][Full Text] [Related]
6. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.
Merten GJ; Burgess WP; Gray LV; Holleman JH; Roush TS; Kowalchuk GJ; Bersin RM; Van Moore A; Simonton CA; Rittase RA; Norton HJ; Kennedy TP
JAMA; 2004 May; 291(19):2328-34. PubMed ID: 15150204
[TBL] [Abstract][Full Text] [Related]
7. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity.
Trivedi HS; Moore H; Nasr S; Aggarwal K; Agrawal A; Goel P; Hewett J
Nephron Clin Pract; 2003 Jan; 93(1):C29-34. PubMed ID: 12411756
[TBL] [Abstract][Full Text] [Related]
8. The use of ionic and nonionic contrast agents and the effects of hydration in the post cardiac transplant patient with moderate renal insufficiency.
Denys BG; Reddy PS; Urestsky BF
Angiology; 1991 Mar; 42(3):218-23. PubMed ID: 2018243
[TBL] [Abstract][Full Text] [Related]
9. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
10. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
11. Radiocontrast nephropathy: is it dose related or not?
Mekan SF; Rabbani MA; Azhar-uddin M; Ali SS
J Pak Med Assoc; 2004 Jul; 54(7):372-4. PubMed ID: 15449920
[TBL] [Abstract][Full Text] [Related]
12. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
13. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ; Katzberg RW; Thomsen HS; Chen N; Sahani D; Soulez G; Heiken JP; Lepanto L; Ni ZH; Ni ZH; Nelson R
Invest Radiol; 2006 Nov; 41(11):815-21. PubMed ID: 17035872
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double-blind randomized comparison in human beings.
Katholi RE; Taylor GJ; Woods WT; Womack KA; Katholi CR; McCann WP; Moses HW; Dove JT; Mikell FL; Woodruff RC
Radiology; 1993 Jan; 186(1):183-7. PubMed ID: 8416561
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure.
Frank H; Werner D; Lorusso V; Klinghammer L; Daniel WG; Kunzendorf U; Ludwig J
Clin Nephrol; 2003 Sep; 60(3):176-82. PubMed ID: 14524580
[TBL] [Abstract][Full Text] [Related]
17. [Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis].
Bouzas-Mosquera A; Vázquez-Rodríguez JM; Calviño-Santos R; Peteiro-Vázquez J; Flores-Ríos X; Marzoa-Rivas R; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Vázquez-González N; Castro-Beiras A
Rev Esp Cardiol; 2007 Oct; 60(10):1026-34. PubMed ID: 17953923
[TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents.
Harris KG; Smith TP; Cragg AH; Lemke JH
Radiology; 1991 Jun; 179(3):849-52. PubMed ID: 2028004
[TBL] [Abstract][Full Text] [Related]
19. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media.
Barrett BJ; Parfrey PS; Vavasour HM; McDonald J; Kent G; Hefferton D; O'Dea F; Stone E; Reddy R; McManamon PJ
Kidney Int; 1992 May; 41(5):1274-9. PubMed ID: 1614041
[TBL] [Abstract][Full Text] [Related]
20. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
